April 8, 2019
Five industry-academia partners including the Jikei University School of Medicine and Sumitomo Dainippon Pharma said on April 5 that they have launched joint R&D of renal regenerative medicine, employing the iPS cell-based organogenic niche method, aiming at commercialization in the...read more